Which ETFs hold Biogen Inc (BIIB)?
American biotech company focused on medicines for neurological conditions like multiple sclerosis.
29 Australian ETFs hold Biogen Inc, a Health Care company from United States. CURE has the biggest weighting at 1.70%. Across these funds, Australian ETF investors own about $44m of Biogen Inc.
The ETFs with the most Biogen Inc
All 29 ETFs that hold Biogen Inc, ranked by weight
Best-endeavours estimate. Built from each issuer's published holdings, which may be weeks or months old, may cover only part of a fund (some publish only their top 10) and are matched by company name. Figures may be incomplete or inaccurate. Check the issuer's website and PDS before relying on them. General information only.
Weights from each issuer's published holdings (September to November 2026). Some funds list only their largest holdings. General information only, not a recommendation to buy or sell Biogen Inc.
Common questions
Which ETF has the most Biogen Inc?
CURE (Global X S&P Biotech ETF) has the highest weighting, with 1.70% of the fund in Biogen Inc.
What is the cheapest ETF that holds Biogen Inc?
Of the ETFs where Biogen Inc is at least 1% of the fund, CURE has the lowest fee at 0.45% a year, with 1.70% in Biogen Inc.
How much Biogen Inc do I own with $10,000 in IVV?
About $6. IVV is the largest ETF that holds Biogen Inc, and Biogen Inc makes up 0.06% of it.
How many Australian ETFs hold Biogen Inc?
29 ETFs listed on the ASX or TMX Australia hold Biogen Inc, based on issuers' published holdings.